Cargando…

Comparison of albicans vs. non-albicans candidemia in French intensive care units

INTRODUCTION: Candidemia raises numerous therapeutic issues for intensive care physicians. Epidemiological data that could guide the choice of initial therapy are still required. This analysis sought to compare the characteristics of intensive care unit (ICU) patients with candidemia due to non-albi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leroy, Olivier, Mira, Jean-Paul, Montravers, Philippe, Gangneux, Jean-Pierre, Lortholary, Olivier
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911735/ https://www.ncbi.nlm.nih.gov/pubmed/20507569 http://dx.doi.org/10.1186/cc9033

Ejemplares similares

Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species
por: Cheng, Ming-Fang, et al.
Publicado: (2005)

Emergence of Non-Albicans Candida Species in Neonatal Candidemia
por: Juyal, Deepak, et al.
Publicado: (2013)

Epidemiology of Candida albicans and non-C.albicans of neonatal candidemia at a tertiary care hospital in western China
por: Fu, Jinjian, et al.
Publicado: (2017)

Top-down characterization data on the speciation of the Candida albicans immunome in candidemia
por: Pitarch, Aida, et al.
Publicado: (2015)

Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study
por: Leroy, Olivier, et al.
Publicado: (2016)

Epidemiology and Prognostic Factors of Non-albicans Candida species Candidemia: A Multicenter Study
por: Lee, Yu-Lin, et al.
Publicado: (2017)

Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units
por: Montravers, Philippe, et al.
Publicado: (2011)

Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010)
por: Lortholary, Olivier, et al.
Publicado: (2014)

Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients
por: Wu, Ping-Feng, et al.
Publicado: (2017)

Impact of Nutritional Assessment on the Clinical Outcomes of Patients with Non-albicans Candidemia: A Multicenter Study
por: Lee, Yi-Chien, et al.
Publicado: (2021)

High Recovery Rate of Non-albicans Candida Species Isolated From Burn Patients With Candidemia in Iran
por: Lotfi, Nazanin, et al.
Publicado: (2015)

Clinical Features and Outcomes of Persistent Candidemia Caused by Candida albicans versus Non-albicans Candida Species: A Focus on Antifungal Resistance and Follow-Up Blood Cultures
por: Kitaya, Shiori, et al.
Publicado: (2023)

Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B
por: Dupont, Bertrand F, et al.
Publicado: (2009)

2447. Clinical Features and Outcome of Persistent Candidemia Caused by Candida albicans versus Non-albicans Candida Species: A Focus on Antifungal Resistance and Follow-up Blood Cultures
por: Kitaya, Shiori, et al.
Publicado: (2023)

Epidemiology, risk factors and outcomes of Candida albicans vs. non-albicans candidaemia in adult patients in Northeast China
por: Zhang, Wei, et al.
Publicado: (2019)

1697. Comparison of Candidemia in Patients in Neonatal Intensive Care Unit and Pediatric Patients and Big Data Analysis on Candidiasis and Candidemia in Korean Children
por: Choi, Joon-sik, et al.
Publicado: (2019)

Recurrent episodes of Candidemia due to Candida glabrata, Candida tropicalis and Candida albicans with acquired echinocandin resistance
por: Grosset, Marine, et al.
Publicado: (2016)

Molecular Fingerprinting Studies Do Not Support Intrahospital Transmission of Candida albicans among Candidemia Patients in Kuwait
por: Asadzadeh, Mohammad, et al.
Publicado: (2017)

Filamentous Non-albicans Candida Species Adhere to Candida albicans and Benefit From Dual Biofilm Growth
por: Pathirana, Ruvini U., et al.
Publicado: (2019)

An Outbreak of Neonatal Candidemia Due to Non-albicans Candida Species in a Resource Constrained Setting of Uttarakhand State, India
por: Juyal, Deepak, et al.
Publicado: (2013)

Clinical Features, Strain Distribution, Antifungal Resistance and Prognosis of Patients with Non-albicans Candidemia: A Retrospective Observational Study
por: Liu, Fengqi, et al.
Publicado: (2021)

Predominance of Candida Glabrata among Non-albicans Candida Species in a 16-Year Study of Candidemia at a Tertiary Care Center in Lebanon
por: Zakhem, Aline El, et al.
Publicado: (2021)

9th Trends in Medical Mycology Held on 11–14 October 2019, Nice, France, Organized under the Auspices of EORTC-IDG and ECMM
por: Gangneux, Jean-Pierre, et al.
Publicado: (2019)

The risk and clinical outcome of candidemia depending on underlying malignancy
por: Lortholary, Olivier, et al.
Publicado: (2017)

Serological Profiling of a Candida albicans Protein Microarray Reveals Permanent Host-Pathogen Interplay and Stage-Specific Responses during Candidemia
por: Mochon, A. Brian, et al.
Publicado: (2010)

Epidemiological cohort study of systemic antifungal therapy for suspected or confirmed invasive candidiasis in the ICU: the Amarcand2 study
por: Constantin, J, et al.
Publicado: (2015)

A renal transplant recipient with intraglomerular Candida albicans
por: Dickson, Zara, et al.
Publicado: (2009)

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017)

Dynamics and Predictors of Mortality Due to Candidemia Caused by Different Candida Species: Comparison of Intensive Care Unit-Associated Candidemia (ICUAC) and Non-ICUAC
por: Kwon, Yong Jun, et al.
Publicado: (2021)

Correction: Serological Profiling of a Candida albicans Protein Microarray Reveals Permanent Host-Pathogen Interplay and Stage-Specific Responses during Candidemia
por: Mochon, A. Brian, et al.
Publicado: (2010)

Risk Factors and Outcomes of Non-albicans Candida Bloodstream Infection in Patients with Candidemia at Siriraj Hospital—Thailand’s Largest National Tertiary Referral Hospital
por: Ngamchokwathana, Chaiyapong, et al.
Publicado: (2021)

Antifungal De-Escalation Is Safe in Critically Ill Patients Treated For Suspected Or Documented Invasive Candidiasis. Data From The Amarcand2 Study
por: Bailly, S, et al.
Publicado: (2015)

Multi-species biofilm of Candida albicans and non-Candida albicans Candida species on acrylic substrate
por: K PATHAK, Apurva, et al.
Publicado: (2012)

Candida periprosthetic joint infections — risk factors and outcome between albicans and non-albicans strains
por: Karczewski, Daniel, et al.
Publicado: (2021)

The role of procalcitonin in neonatal intensive care unit patients with candidemia
por: Montagna, Maria Teresa, et al.
Publicado: (2012)

Risk prediction for candidemia in surgical intensive care unit patients
por: Kilic, Aysegul Ulu, et al.
Publicado: (2020)

Candida albicans versus Candida dubliniensis: Why Is C. albicans More Pathogenic?
por: Moran, Gary P., et al.
Publicado: (2012)

Growth of Aspergillus fumigatus in Biofilms in Comparison to Candida albicans
por: Subroto, Eefje, et al.
Publicado: (2022)

Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
por: Mandras, Narcisa, et al.
Publicado: (2016)

Candida albicans susceptibility to lactoperoxidase-generated hypoiodite
por: Ahariz, Mohamed, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_jm121ift1egrjorg0itpes6u5s